Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit

Rhea-AI Summary

Generation Bio (Nasdaq: GBIO), a biotechnology company focused on genetic medicines for rare and prevalent diseases, announced that its CEO, Dr. Geoff McDonough, will participate in a fireside chat at the virtual 2024 TD Cowen Genetic Medicines & RNA Summit.

The event will take place on June 21, 2024, at 1:50 p.m. ET. The presentation will be live-streamed on the company's investor website, with a replay available for 30 days.

Positive

• Participation in a high-profile event like the 2024 TD Cowen Genetic Medicines & RNA Summit boosts company visibility.
• Live webcast ensures accessibility to a broad audience, potentially attracting new investors.
• Replay availability for 30 days can extend the impact of the presentation.

Negative

• No new clinical data or financial updates were provided in the announcement.
• The event is virtual, which may limit networking opportunities compared to in-person events.

CAMBRIDGE, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the virtual 2024 TD Cowen Genetic Medicines & RNA Summit on Friday, June 21^st, 2024 at 1:50 p.m. ET.

A live webcast of the presentation will be available on the investor section of the company’s website at investors.generationbio.com. A replay will be available there for 30 days following the event.

About Generation Bio

Generation Bio is innovating non-viral genetic medicines to provide durable and redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The company is developing two distinct and complementary platforms: a potent, highly selective cell-targeted lipid nanoparticle (ctLNP) delivery system and a novel immune-quiet DNA (iqDNA) cargo produced by a scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis (RES). With these platforms, Generation Bio aims to develop the next wave of non-viral genetic medicines to support its mission to extend the reach of genetic medicine to more people living with more diseases, around the world.

For more information, please visit www.generationbio.com.

Investors and Media Contact
Maren Killackey
Generation Bio
mkillackey@generationbio.com
857-371-4638

FAQ

What is Generation Bio presenting at the 2024 TD Cowen Genetic Medicines & RNA Summit?

Generation Bio's CEO, Dr. Geoff McDonough, will participate in a fireside chat at the summit on June 21, 2024.

When is Generation Bio presenting at the 2024 TD Cowen Genetic Medicines & RNA Summit?

The presentation is scheduled for June 21, 2024, at 1:50 p.m. ET.

Where can I watch the Generation Bio presentation from the 2024 TD Cowen Genetic Medicines & RNA Summit?

The live webcast will be available on the investor section of Generation Bio's website. A replay will be available for 30 days.

What is the stock symbol for Generation Bio?

The stock symbol for Generation Bio is GBIO.